Intraoperative radiofrequency ablation of the atrium: effectiveness for treatment of supraventricular tachycardia in congenital heart surgery (original) (raw)
Related papers
Journal of the American College of Cardiology, 2002
The goal of this study was to identify factors associated with radiofrequency catheter ablation (RFCA) outcomes of intra-atrial re-entrant tachycardia (IART). BACKGROUND Radiofrequency catheter ablation of IART is difficult. The influence of patient and procedural factors and novel technologies on outcomes is unknown. METHODS Acute and chronic RFCA outcomes were studied in patients with congenital heart disease and IART. Clinical status was measured using a multiaxis severity score. Multivariate analyses identified associations of clinical, procedural and technological factors with outcomes. RESULTS A total of 177 procedures were performed in 134 patients; 139 procedures (79%) resulted in RFCA of Ն1 IART circuit and 117 (66%) in RFCA of all targeted circuits. Multivariate analysis associated acute success with irrigated ablation and absence of atrial fibrillation. Twenty-two complications were noted, nine related to vascular access. Electroanatomic mapping failed to decrease procedure or fluoroscopy time. Improvement in clinical status occurred in most patients (severity score preablation: 6.2 Ϯ 1.6, postablation: 3.0 Ϯ 2.3, p Ͻ 0.0001). At mean follow-up of 25 Ϯ 11 months, 42% of patients had IART recurrence and 28% required cardioversion. Six deaths occurred (1.8%/patient-year), and two patients underwent transplant. Chronic outcomes were associated with higher right atrial saturations, use of electroanatomic mapping, fewer IART circuits encountered and acute procedural success. CONCLUSIONS Improvement of acute RFCA outcomes was contemporaneous with introduction of novel technologies. Intra-atrial re-entrant tachycardia recurrence was common, and no effect on mortality was discerned, but most patients had effective palliation of symptoms. Chronic outcome predictors included the underlying disease severity, application of novel technologies and successful ablation of all targeted arrhythmia circuits.
Europace, 2011
In patients with tetralogy of Fallot (ToF), inducible sustained VT is associated with approximately five-fold risk of sudden cardiac death or clinical sustained VT. 2 Patients with Rastelli repairs have potential substrates for the development of macro-reentrant VT as per repaired ToF, including VSD patches and RV suture lines. The approach to VT ablation in patients with congenital heart disease is founded on review of all imaging studies, original surgical/ interventional reports, and documented tachyarrhythmias. In the current case, identified anatomical and electrical barriers to conduction around which circuits may propagate included the Rastelli conduit, patch-repaired VSD, TA, and RVOT. When activation and entrainment mapping cannot be performed due to non-inducibility or haemodynamic instability, pace-mapping and/or non-contact mapping can be utilized. In our patient due to the presence of a scar around and in proximity to the outflow tract extensive pace mapping of potential macro re-entry isthmi was also undertaken to exclude an exit site from a potential macro re-entry circuit. Interestingly, the suspected site was located within the native remnant RVOT, where ablation was performed in sinus rhythm. High rates of appropriate ICD shocks occur in primary and secondary prevention patients with repaired ToF. 3 The only predictor of appropriate ICD shocks was a prior ventriculotomy incision. For such patients, VT ablation is not a stand-alone therapy for the prevention of sudden cardiac death. Conclusion Ventricular tachycardia appears to be infrequent following Rastelli repair, but have been poorly characterized. This case demonstrates the feasibility, safety, and potential efficacy of RVOT VT ablation in the setting of Rastelli repair.
Radiofrequency Catheter Ablation of Tachycardia in Patients with Congenital Heart Disease
Pediatric Cardiology, 2000
Patients with anomalies of the heart frequently suffer from arrhythmias that either are associated with a congenital heart defect or result from the course of the disease. For most of the bradyarrhythmias, appropriate timing of the initiation of treatment is more challenging than its eventual execution. In the case of tachycardias, technical aspects of treatment require more attention because the often imperative impact such tachycardias have on quality of life, morbidity, and mortality determine intervention timing. Increasingly, interventional electrophysiology is turned to as a potentially definitive and substrate-related treatment because of antiarrhythmic drug therapy's failure to prevent arrhythmia recurrences and the potential detrimental side effects from drug therapy seen in this particular patient population. Using the experience gained during the past 10 years in the treatment of patients with arrhythmias but without associated structural heart disease, several groups reported their results and difficulties with the application of such therapy to patients with congenital heart defects. In this report, we summarize our hospital's experience with transcatheter radiofrequency current application for treatment of various types of tachyarrhythmias in 139 children and adults with congenital heart defects, emphasizing the current limitations of such therapy and addressing the potential benefits expected from future technology. Patient ages ranged from 5 months to 76 years (mean 25.3 ± 17.7 years), including 56 children and adolescents less than 16 years of age. At least one attempt at surgical palliation or correction was made in 93 patients; the remaining 46 patients had no surgical intervention attempts. A total of 225 different tachycardias were found, 93 of which were based on a congenital arrhythmogenic substrate (e.g., an accessory pathway). Acquired substrates (e.g., scars or myocardial fibrosis) gave rise to the remaining 132 tachycardias. Radiofrequency current ablation (183 sessions) successfully treated 121 of 139 patients. Within a follow-up period of 21 months a recurrence of the intrinsically treated tachycardia was seen in 24 patients (10.7%); 13 of the 24 underwent a successful repeat session. There were no significant pro-cedure-related complications. Young and adult patients with congenital heart disease can be safely and successfully treated for tachycardias with the use of radiofrequency current ablation. Because such treatment meets the specific needs of this patient group, early consideration for this therapy is recommended.
International Journal of Cardiology, 1995
Radiofrequency catheter ablation was performed in 21 patients who had congenital heart diseases associated with accessory pathway (AP)-mediated tachycardia (14 patients), with atrioventricular (AV) nodal reentrant tachycardia (4 patients), with intraatrial reentrant tachycardia (1 patient), with coexistent AP mediated tachycardia and AV nodal reentrant tachycardia (1 patient) and with coexistent AV nodal reentrant tachycardia and atria1 tachycardia (1 patient). Congenital heart diseases diagnosed were seven with Ebstein's anomaly and six with septal defect; the others included patent ductus arteriosus, supravalvular aortic stenosis and left superior vena cava-coronary sinus Iistula. Incidence of multiple APs (26.7 vs. 7.7%, P = 0.027), antidromic tachycardia (20.0 vs. 2.9%, P = 0.01 l), tachyarrhythmia-related syncope (26.7 vs. 7.2%, P = 0.022) and cardiac arrest (13.3 vs. 0%, P = 0.001) was higher in patients with AP and congential heart diseases. Longer procedure (3.9 i 0.7 vs. 2.4 f 1.3 h for AP, P = 0.001; 3.0 f 0.7 vs. 2.5 f 0.8 h for AV nodal reentrant tachycardia, P = O.OOl), and radiation exposure times (102 f 27 vs. 35 f 23 min for AP, P = 0.001; 62 f 23 vs. 20 f 11 min for AV nodal reentrant tachycardia, P = 0.001) were necessary to achieve a high success rate (95%) in patients with congential heart disease.
JACC. Clinical electrophysiology, 2018
The aim of this study was to analyze the long-term outcomes after intra-atrial re-entrant tachycardia (IART) ablation in congenital heart disease (CHD). IART increases morbidity and mortality in CHD patients. Radiofrequency catheter ablation has evolved into the first-line treatment of this complication. This was a prospective, single-center study of all consecutive CHD patients who underwent first ablation for IART from January 2009 to December 2015 (n = 94, 39.4% female, age 36.55 ± 14.9 years, follow-up 44.45 ± 22.7 months). During the study period, 130 procedures were performed (n = 94, 1.21 ± 0.41 IART/patient). In the first procedure, 114 IART were ablated (short-term success 74.66%). Forty-nine percent of the patients whose IART was ablated had non-cavotricuspid isthmus (CTI)-related IART (alone or with concomitant CTI IART). After the first ablation, 54.3% maintained sinus rhythm (SR), 23.9% presented with recurrence of the ablated IART, 14.2% developed new IART, and 7.6% pr...
Journal of the American Heart Association, 2018
Intra-atrial re-entrant tachycardia (IART) in patients with congenital heart disease (CHD) increases morbidity and mortality. Radiofrequency catheter ablation has evolved as the first-line treatment. The aim of this study was to analyze the acute success and to identify predictors of failed IART radiofrequency catheter ablation in CHD. The observational study included all consecutive patients with CHD who underwent a first ablation procedure for IART at a single center from January 2009 to December 2015 (94 patients, 39.4% female, age: 36.55±14.9 years). In the first procedure, 114 IART were ablated (acute success: 74.6%; 1.21±0.41 IART per patient) with an acute success of 74.5%. Cavotricuspid isthmus-related IART was the only arrhythmia in 51%; non-cavotricuspid isthmus-related IART was the only mechanism in 27.7% and 21.3% of the patients had both types of IART. Predictors of acute radiofrequency catheter ablation failure were as follows: nonrelated cavotricuspid isthmus IART (od...
Circulation, 2001
Background-The purpose of the present study was to determine the role of a novel, noncontact mapping system for assessing a variety of atrial reentrant tachycardias (ART) in patients after the surgical correction of congenital heart disease. Methods and Results-In 14 patients, an electrophysiological study using the Ensite 3000 system was performed to assess ARTs resistant to medical treatment. Sixteen different forms of ART were inducible in the 14 patients studied. The reentrant circuit of all ARTs could be characterized and localized with respect to anatomic landmarks such as atriotomy scars, intraatrial patches/baffles, and cardiac structures. In 15 of the 16 ARTs (in 13 of the 14 patients), a target area of the reentrant circuit for radiofrequency current application (ie, an area of conduction between 2 anatomical obstacles such as surgical barriers and cardiac structures of electrical isolation) could be localized within the systemic venous atrium. Nine patients exhibited macroreentry, and 4 showed microreentry. In 12 patients, ART could be terminated by creating linear radiofrequency current lesions (75°C, 180 to 390 s). Completeness of linear lesions after radiofrequency current delivery was proven by analyzing color-coded isopotential maps of atrial activation while applying atrial pacing techniques. The mean duration of the procedures was 286 minutes (range, 130 to 435 minutes); fluoroscopy time ranged from 7 to 33.8 minutes (mean, 17.4 minutes). Conclusions-In patients with ART after the surgical correction of congenital heart disease, the use of the noncontact mapping system allows for characterization of the tachycardia and guidance for effective radiofrequency current delivery.